# Evonik Venture Capital

> Evonik Venture Capital is a VC fund backing Biotechnology and Manufacturing. See 40 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Hanau, Germany
- Total investments: 40
- Last investment: Sep 2024
- Lead investor: 40%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/evonik
- Website: http://venturing.evonik.com

Evonik Venture Capital is a VC fund in Hanau focused on Biotechnology and Manufacturing. Evonik Venture Capital is the corporate venture arm of Evonik Industries AG, one of the providers of specialty chemicals. Evonik Venture Capital invests in young companies with innovative technology and high growth potential with solutions to problems within the areas of focus of resource efficiency, specialty additives, health & care,nutrition.

## Contacts

5 contacts available for Evonik Venture Capital. Shizune tracks 5 team members at Evonik Venture Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/evonik-venture-capital-gmbh?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $3M–$15M |
| Venture - Series Unknown | $14M–$39M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 9 | 23% |
| Manufacturing | 8 | 20% |
| Health Care | 7 | 18% |
| Software | 4 | 10% |
| 3D Printing | 4 | 10% |

54 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 7 | 18% |
| Funding Round | 6 | 15% |
| Venture - Series Unknown | 5 | 13% |
| Series B | 4 | 10% |
| Series C | 4 | 10% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 8 | 20% |
| China | 4 | 10% |
| The Netherlands | 3 | 8% |
| Israel | 2 | 5% |
| Finland | 2 | 5% |

10 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Bernhard Mohr | Managing Director | 16 | https://shizune.co/investors/profile/dr-bernhard-mohr |
| Eric Breese | Investment Director | 0 | https://shizune.co/investors/profile/eric-breese |
| Lars Bönisch | Venture Capitalist | 1 | https://shizune.co/investors/profile/lars-b%C3%B6nisch |
| Lutz Stoeber | Investment Director | 1 | https://shizune.co/investors/profile/lutz-stoeber |
| Thomas Grosse-Puppendahl | Vice President, Operations | 3 | https://shizune.co/investors/profile/thomas-grosse-puppendahl |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Abolis Biotechnologies | Abolis is a French company delivering high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms. Founded in 2014, Abolis is made up of a team of over 54 people, sharing a scientific and humanistambition. Determined to become a key player in the transformation of manufacturing, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals. We help industries make the ecological transition by rethinking their production models We rely on biotechnologies and the untapped potential of micro-organisms to develop new bioproduction solutions that are economically and ecologically sustainable alternatives to petrochemical products and chemical ingredients. We take up the industry's current challenges by: ·      Using renewable raw materials ·      Relocate essential production and secure supply chains ·      Designing biocompatible products less toxic for the environment ·      Reducing greenhouse gas emissions Abolis is providing tailor-made industrial solutions, based on microorganisms We are… independent in thought and action rigorous in our approach and the way we work creative because we never stop innovating, while remaining pragmatic ambitious because we are passionate and determined to make a difference | $38.8M | Venture - Series Unknown | Sep 12, 2024 |  |
| Strohm | Strohm is a private supply chain company, focused on the offshore wind-to-hydrogen sector. | $31.8M | Venture - Series Unknown | Jun 19, 2024 |  |
| Velox | Velox develops and manufactures industrial-grade direct-to shape digital decoration solutions for the rigid container industry. Their proprietary DTS-Inkjet technology, based on uniquely formulated inks and dedicated deposition architecture, introduces an entirely new approach to digital printing that is poised to disrupt the packaging decorationmarket.Their debut product is the Velox IDS 250 – the first industrial-grade digital decorator for mass production of cylindrical containers available on the market. It delivers superior decoration quality and capabilities that outstrip analog printing solutions, while allowing a more efficient and flexible production process and a low total cost of ownership (TCO).Velox is powered by an expert team with uniquely extensive and wide-ranging experience in digital printing. It is led by veteran executives with proven success in driving company growth. | $38M | Series B | Apr 02, 2024 |  |
| Jiangsu Jland Biotech | Jiangsu Jland Biotech is dedicated to the development and production of Biollagen™ collagen and is determined to be the biggest non-animal-sourced collagen supplier worldwide. |  | Series B | Sep 25, 2023 |  |
| HPNow | HPNow is pioneering the market introduction of powerful, autonomous, safe and eco-friendly water and air treatment solutions, based on their technological breakthroughs in on-site generation of hydrogen peroxide. HPNow’s technology enables on-demand, highly-efficient production of hydrogen peroxide using only water, electricity and air.Withtheir compact and autonomous on-site HPGenTM hydrogen-peroxide generators, they are set to displace presently used and increasingly regulated chlorine and other toxic-chemical disinfectants across multiple water and air treatment sectors. In doing so they will provide our users with cost savings, reduced logistical burdens, and increased yields, while enhancing water, air and food safety and reducing the environmental impact of today’s toxic disinfectant agents. | $15M | Series A | Sep 19, 2023 |  |
| SuperC | SuperC is an enterprise that specializes in the research and production of innovative nanomaterials. The company was founded in 2012 and is headquartered in Dongguan City, Guangdong, China. |  | Venture - Series Unknown | Feb 20, 2023 |  |
| SuperC | SuperC is an enterprise that specializes in the research and production of innovative nanomaterials. The company was founded in 2012 and is headquartered in Dongguan City, Guangdong, China. |  | Venture - Series Unknown | Feb 20, 2023 |  |
| Strohm | Strohm is a private supply chain company, focused on the offshore wind-to-hydrogen sector. | $16M | Venture - Series Unknown | Dec 15, 2022 |  |
| Allay Therapeutics | Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation. The company was founded in 2017 and is headquartered in Menlo Park, California, United States. |  | Series C | Dec 13, 2022 |  |
| Strohm | Strohm is a private supply chain company, focused on the offshore wind-to-hydrogen sector. | $14.4M | Venture - Series Unknown | Aug 12, 2022 |  |

10 of 40 investments shown.

## Co-investors
- [Clay Capital](https://shizune.co/investors/profile/new-protein-capital) — VC Fund, 6 deals together
- [TAU Ventures](https://shizune.co/investors/profile/tau-ventures) — VC Fund, 4 deals together
- [Chevron Technology Ventures](https://shizune.co/investors/profile/chevron-technology-ventures) — VC Fund, 3 deals together
- [HydrogenOne Capital](https://shizune.co/investors/profile/hydrogenone-capital) — VC Fund, 3 deals together
- [Shell Ventures](https://shizune.co/investors/profile/shell-technology-ventures) — VC Fund, 3 deals together
- [Spring Ventures](https://shizune.co/investors/profile/spring-ventures-2) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [F6 Ventures](https://shizune.co/investors/profile/flat6labs) — VC Fund
- [Oqal](https://shizune.co/investors/profile/oqal) — VC Fund
- [Alesta Yatırım](https://shizune.co/investors/profile/alesta-girisim) — VC Fund

## Featured in investor lists
- [Manufacturing VC Funds in Israel](https://shizune.co/investors/manufacturing-vc-funds-israel)
- [Enterprise Software VC Funds in Middle East](https://shizune.co/investors/enterprise-software-vc-funds-middle-east)
- [Manufacturing Investors in Israel](https://shizune.co/investors/manufacturing-investors-israel)
- [Manufacturing Investors in Middle East](https://shizune.co/investors/manufacturing-investors-middle-east)
- [Manufacturing VC Funds in Middle East](https://shizune.co/investors/manufacturing-vc-funds-middle-east)
- [Enterprise Software Investors in Middle East](https://shizune.co/investors/enterprise-software-investors-middle-east)

## FAQ

### What does Evonik Venture Capital invest in?

Evonik Venture Capital invests primarily in Biotechnology, Manufacturing and Health Care startups, most often at Series A and Funding Round stage. Most of the 40 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Evonik Venture Capital's check size?

Evonik Venture Capital typically joins rounds of $3M–$15M at Series A and $14M–$39M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Evonik Venture Capital participates in.

### How do I contact Evonik Venture Capital?

Public channels for Evonik Venture Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Evonik Venture Capital?

The team at Evonik Venture Capital includes Bernhard Mohr (Managing Director), Eric Breese (Investment Director) and Lars Bönisch (Venture Capitalist). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co